| Field | Row 1 |
|---|---|
| adsh | 0001079973-25-000729 |
| cik | 788920 |
| name | PRO DEX INC |
| sic | 3841 |
| countryba | US |
| stprba | CA |
| cityba | IRVINE |
| zipba | 92614 |
| bas1 | 2361 MCGAW AVENUE |
| bas2 | |
| baph | 949-769-3231 |
| countryma | US |
| stprma | CA |
| cityma | IRVINE |
| zipma | 92614 |
| mas1 | 2361 MCGAW AVENUE |
| mas2 | |
| countryinc | |
| stprinc | |
| ein | 841261240 |
| former | PRO-DEX, INC. |
| changed | 20151110 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0630 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q3 |
| filed | 20250501 |
| accepted | 2025-05-01 16:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | pdex_033125-10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 4513000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers; | ||
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 3077000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Total Suppliers; | ||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 5962000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers; | ||
| 0001079973-25-000729 | 20250331 | Accounts Receivable Net Current | 15861000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Accrued Liabilities Current | 3359000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Assets Current | 36611000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Deferred Income Tax Assets Net | 1555000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Depreciation Depletion And Amortization | 854000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Gain Loss On Sale Of Investments | 595000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 704000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Accounts Receivable | 1974000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Deferred Charges | -121000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Interest Paid Net | 409000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Liabilities | 21610000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Liabilities Current | 18317000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Net Income Loss | 3275000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Noncash Or Part Noncash Acquisition Inventory Acquired1 | 885000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Noncash Or Part Noncash Acquisition Inventory Acquired1 | 2090000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Other Assets Noncurrent | 42000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Other Assets Noncurrent | 44000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Other Nonoperating Income Expense | 15000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Payments Of Employee Taxes On Net Issuance Of Common Stock | USD | 3 | 0001079973-25-000729 | ||||
| 0001079973-25-000729 | 20240331 | Payments To Acquire Investments | 1250000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Payments To Acquire Property Plant And Equipment | 1153000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Research And Development Expense | 2353000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Revenues | 1917000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer2; | ||
| 0001079973-25-000729 | 20250331 | Revenues | 15314000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Total Customer; | ||
| 0001079973-25-000729 | 20240630 | Stockholders Equity | 30867000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20241231 | Stockholders Equity | 366000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stockholders Equity | 35282000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Other | -305000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Repurchased During Period Value | 1723000.0000 | USD | 1 | us-gaap/2024 | Plan Name= Tenb51 Plan; Share Repurchase Program= Share Repurchase Program; | ||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 3451423.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 3531249.0000 | shares | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3261043.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2631000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Earnings Per Share Basic | 2.3600 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Earnings Per Share Diluted | 0.1900 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Retained Earnings Accumulated Deficit | 26950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | General And Administrative Expense | 1098000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | General And Administrative Expense | 3732000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Income Tax Expense Benefit | 258000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Income Tax Expense Benefit | 1279000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1601000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | -247000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Deferred Revenue | -14000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Interest Expense | 138000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Liabilities Current | 12892000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Income Loss | 655000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | Operating Expenses | 5640000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Expenses | 2158000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Income Loss | 3640000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Income Loss | 9345000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Proceeds From Sale Of Equity Method Investments | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | Repayments Of Notes Payable | 2990000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Research And Development Expense | 947000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 27491000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer1; | ||
| 0001079973-25-000729 | 20250331 | Revenues | 43826000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Total Customer; | ||
| 0001079973-25-000729 | 20240331 | Selling Expense | 79000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Stockholders Equity | 5575000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240630 | Stockholders Equity | 26950000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20240331 | Stock Repurchased During Period Value | -1722000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stock Repurchased During Period Value | -3504000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 1405000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers1; | ||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 2192000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Total Suppliers; | ||
| 0001079973-25-000729 | 20240630 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Common Stock Shares Outstanding | 3261043.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Cost Of Revenue | 28357000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Credit Loss Expense | 1000.0000 | USD | 3 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20240630 | Deferred Costs Current | 262000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Earnings Per Share Diluted | 0.1500 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Earnings Per Share Diluted | 0.9800 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Gross Profit | 5798000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Income Taxes Paid Net | 3190000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Income Tax Expense Benefit | 2678000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | -63000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 776000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Interest Expense | 246000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Liabilities And Stockholders Equity | 64273000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Liabilities Noncurrent | 8718000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Liabilities Noncurrent | 10674000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Cash Provided By Used In Financing Activities | -2770000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Cash Provided By Used In Investing Activities | -2126000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Net Cash Provided By Used In Investing Activities | 754000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Net Cash Provided By Used In Operating Activities | -1509000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Prepaid Expense And Other Assets Current | 619000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 50000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 42000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Proceeds From Sale Of Equity Method Investments | 1907000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Property Plant And Equipment Other Net | 6155000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Retained Earnings Accumulated Deficit | 34731000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 14293000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 14293000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer; | ||
| 0001079973-25-000729 | 20240331 | Revenues | 4087000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer2; | ||
| 0001079973-25-000729 | 20240331 | Revenues | 31578000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Total Customer; | ||
| 0001079973-25-000729 | 20250331 | Short Term Investments | 5417000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20230630 | Stockholders Equity | 31590000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Stockholders Equity | 3917000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001079973-25-000729 | 20191231 | Stock Repurchased During Period Value | 24200000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Cumulative Basis; Plan Name= Tenb51 Plan; Share Repurchase Program= Share Repurchase Program; | ||
| 0001079973-25-000729 | 20240331 | Unrealized Gain Loss On Investments | -3785000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3296744.0000 | shares | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 416000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers2; | ||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 5962000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Accrued Liabilities Current | 3542000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Allowance For Doubtful Accounts Receivable Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Assets | 64273000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 283000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Cash Equivalents At Carrying Value | 4473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Common Stock Shares Issued | 3363412.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Cost Of Revenue | 10291000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Credit Loss Expense | USD | 3 | 0001079973-25-000729 | ||||
| 0001079973-25-000729 | 20250331 | Earnings Per Share Diluted | 2.3100 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Gross Profit | 10462000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 10459000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Deferred Charges | -163000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Deferred Revenue | 35000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 277000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Intangible Assets Net Excluding Goodwill | 33000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Net Income Loss | 3275000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Net Income Loss | 7781000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20240331 | Noncash Or Part Noncash Acquisition Other Assets Acquired1 | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | Other Nonoperating Income Expense | 76000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Payments To Acquire Investments | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | Research And Development Expense | 760000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Revenues | 13397000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer1; | ||
| 0001079973-25-000729 | 20250331 | Selling Expense | 211000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20230630 | Stockholders Equity | 6767000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20231231 | Stockholders Equity | 24708000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20240331 | Stockholders Equity | 25363000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Stockholders Equity | 551000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 50000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stock Repurchased During Period Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001079973-25-000729 | 20250331 | Stock Repurchased During Period Value | 3500000.0000 | USD | 3 | us-gaap/2024 | Plan Name= Tenb51 Plan; Share Repurchase Program= Share Repurchase Program; | ||
| 0001079973-25-000729 | 20250331 | Unrealized Gain Loss On Investments | 1060000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 3603649.0000 | shares | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3337312.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | 3451423.0000 | shares | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | 3261043.0000 | shares | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Noncash Straightline Lease Amortization | -12000.0000 | USD | 3 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 430000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers3; | ||
| 0001079973-25-000729 | 20240630 | Allowance For Doubtful Accounts Receivable Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Cash Equivalents At Carrying Value | 2631000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Common Stock Value | 3917000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Cost Of Revenue | 33080000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Deferred Costs Current | 141000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Deferred Revenue Current | USD | 0 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20250331 | Depreciation Depletion And Amortization | 925000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Earnings Per Share Basic | 0.1500 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Equity Method Investment Realized Gain Loss On Disposal | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20250331 | Equity Method Investment Realized Gain Loss On Disposal | 595000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Gain Loss On Sale Of Investments | USD | 3 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | General And Administrative Expense | 1012000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Income Tax Expense Benefit | 164000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Inventories | -1925000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Increase Decrease In Inventories | 8163000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Intangible Assets Net Excluding Goodwill | 54000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Liabilities And Stockholders Equity | 52477000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Long Term Investments | 1563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Long Term Notes Payable | 9861000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Notes Payable Current | 4374000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Operating Expenses | 1789000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Proceeds From Issuance Of Long Term Debt | 2000000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Proceeds From Issuance Of Long Term Debt | 12890000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Repayments Of Notes Payable | 6526000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 38819000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 38819000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer; | ||
| 0001079973-25-000729 | 20240331 | Selling Expense | 17000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20231231 | Stockholders Equity | 7078000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 18000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Other | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001079973-25-000729 | 20240331 | Unrealized Gain Loss On Investments | -1192000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Unrealized Gain Loss On Investments | 550000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 3523823.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 652000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers2; | ||
| 0001079973-25-000729 | 20250331 | Accrued Income Taxes Current | 385000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Assets | 52477000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Assets Current | 49943000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Earnings Per Share Basic | 0.1900 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Earnings Per Share Basic | 1.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Equipment And Leasehold Improvements Net | 5024000.0000 | USD | 0 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20240331 | Equity Method Investment Realized Gain Loss On Disposal | USD | 1 | us-gaap/2024 | ||||
| 0001079973-25-000729 | 20240331 | General And Administrative Expense | 3208000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Gross Profit | 4002000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 4554000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Income Taxes Paid Net | 980000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 710000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Interest Expense | 409000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Interest Expense | 602000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Stockholders Equity | 30938000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20241231 | Stockholders Equity | 31822000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Interest Paid Net | 573000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Inventory Net | 15269000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Liabilities | 28991000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Net Cash Provided By Used In Financing Activities | 2597000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Cash Provided By Used In Operating Activities | 5179000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Income Loss | 655000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20240331 | Net Income Loss | 540000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Net Income Loss | 7781000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Noncash Or Part Noncash Acquisition Payables Assumed1 | 74000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Expenses | 6674000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Lease Liability Noncurrent | 813000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Operating Lease Right Of Use Asset | 1473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Operating Lease Right Of Use Asset | 1158000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Payments For Repurchase Of Common Stock | 3504000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Payments To Acquire Property Plant And Equipment | 876000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Prepaid Expense And Other Assets Current | 345000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Property Plant And Equipment Other Net | 6085000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 1385000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer2; | ||
| 0001079973-25-000729 | 20240331 | Revenues | 12064000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Total Customer; | ||
| 0001079973-25-000729 | 20230630 | Stockholders Equity | 24823000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 42000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Share Based Compensation | 588000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Share Based Compensation | 158000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Share Based Compensation | 401000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Repurchased During Period Value | -1830000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Repurchased During Period Value | 1830000.0000 | USD | 3 | us-gaap/2024 | Plan Name= Tenb51 Plan; Share Repurchase Program= Share Repurchase Program; | ||
| 0001079973-25-000729 | 20240331 | Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | 3451423.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | 3261043.0000 | shares | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Accounts Payable Current | 1995000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers1; | ||
| 0001079973-25-000729 | 20240630 | Accounts Receivable Net Current | 13887000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Accrued Income Taxes Current | 632000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Amortization Of Deferred Loan Origination Fees Net | 6000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Amortization Of Deferred Loan Origination Fees Net | -16000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3219000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 1842000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Common Stock Shares Issued | 3261043.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Cost Of Revenue | 11616000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Deferred Income Tax Assets Net | 1555000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Deferred Revenue Current | 14000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Gross Profit | 16019000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Increase Decrease In Accounts Receivable | 2565000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Inventory Net | 23432000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 | 21000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Noncash Or Part Noncash Acquisition Other Assets Acquired1 | 117000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Noncash Straightline Lease Amortization | -24000.0000 | USD | 3 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20250331 | Notes Payable Current | 8428000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Other Nonoperating Income Expense | 61000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Revenues | 10679000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer1; | ||
| 0001079973-25-000729 | 20250331 | Revenues | 49099000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Revenues | 49099000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer; | ||
| 0001079973-25-000729 | 20250331 | Revenues | 5538000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer2; | ||
| 0001079973-25-000729 | 20240630 | Short Term Investments | 4217000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20231231 | Stockholders Equity | 31786000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20241231 | Stockholders Equity | 31456000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 27000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240331 | Stock Issued During Period Value Share Based Compensation | 201000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 4513000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Accounts Payable Current | 371000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Accounts Payable; Concentration Risk By Type= Supplier Concentration Risk; Major Customers= Suppliers3; | ||
| 0001079973-25-000729 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2936000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Common Stock Shares Outstanding | 3363412.0000 | shares | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Common Stock Value | 551000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Equipment And Leasehold Improvements Net | 5344000.0000 | USD | 0 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20250331 | Equity Method Investment Realized Gain Loss On Disposal | 595000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Long Term Investments | 111000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Long Term Notes Payable | 7536000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Net Income Loss | 540000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Noncash Or Part Noncash Acquisition Payables Assumed1 | 1100000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Operating Income Loss | 2213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Operating Income Loss | 4822000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240630 | Operating Lease Liability Noncurrent | 1182000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Other Nonoperating Income Expense | 30000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Payments For Repurchase Of Common Stock | 1830000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Payments Of Employee Taxes On Net Issuance Of Common Stock | 305000.0000 | USD | 3 | 0001079973-25-000729 | |||
| 0001079973-25-000729 | 20250331 | Research And Development Expense | 2731000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Revenues | 17414000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Revenues | 17414000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer; | ||
| 0001079973-25-000729 | 20250331 | Revenues | 38288000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Sales; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Customer1; | ||
| 0001079973-25-000729 | 20250331 | Selling Expense | 113000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20240331 | Share Based Compensation | 588000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Share Based Compensation | 401000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001079973-25-000729 | 20250331 | Stockholders Equity | 34731000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001079973-25-000729 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3366099.0000 | shares | 3 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Proceeds From Issuance Of Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Long-Term Debt | The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Allowance For Doubtful Accounts Receivable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss, Current | Amount of allowance for credit loss on accounts receivable, classified as current. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Deferred Revenue Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Payments To Acquire Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash Equivalents, at Carrying Value | Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Selling Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling Expense | Expenses recognized in the period that are directly related to the selling and distribution of products or services. |
| Unrealized Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Equity Method Investment Realized Gain Loss On Disposal | us-gaap/2024 | 0 | 0 | monetary | D | C | Equity Method Investment, Realized Gain (Loss) on Disposal | Amount of gain (loss) on sale or disposal of an equity method investment. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Stock Repurchased During Period Value | us-gaap/2024 | 0 | 0 | monetary | D | D | Stock Repurchased During Period, Value | Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. |
| Accrued Income Taxes Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Income Taxes, Current | Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. |
| Noncash Straightline Lease Amortization | 0001079973-25-000729 | 1 | 0 | monetary | D | D | Non-cash straight-line lease amortization | |
| Payments Of Employee Taxes On Net Issuance Of Common Stock | 0001079973-25-000729 | 1 | 0 | monetary | D | C | PaymentsOfEmployeeTaxesOnNetIssuanceOfCommonStock | |
| Amortization Of Deferred Loan Origination Fees Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Amortization of Deferred Loan Origination Fees, Net | The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments. |
| Common Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, No Par Value | Face amount per share of no-par value common stock. | |
| Increase Decrease In Deferred Charges | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Charges | The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Long Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Long-Term Investments | The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Noncash Or Part Noncash Acquisition Payables Assumed1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Noncash or Part Noncash Acquisition, Payables Assumed | The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Property Plant And Equipment Other Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Other, Net | Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other. |
| Repayments Of Notes Payable | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Notes Payable | The cash outflow for a borrowing supported by a written promise to pay an obligation. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Credit Loss Expense | 0001079973-25-000729 | 1 | 0 | monetary | D | D | Credit loss expense | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Proceeds From Sale Of Equity Method Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Equity Method Investments | The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Payments For Repurchase Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Noncash Or Part Noncash Acquisition Other Assets Acquired1 | us-gaap/2024 | 0 | 0 | monetary | D | D | Noncash or Part Noncash Acquisition, Other Assets Acquired | Amount of assets, classified as other, acquired in a noncash or part noncash acquisition. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Deferred Costs Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Costs, Current | Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Gain Loss On Sale Of Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Sale of Investments | The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Noncash Or Part Noncash Acquisition Inventory Acquired1 | us-gaap/2024 | 0 | 0 | monetary | D | D | Noncash or Part Noncash Acquisition, Inventory Acquired | The amount of inventory that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Limited Partnership and General Partnership Unit Outstanding, Basic and Diluted | The average number of limited partnership and general partnership units issued and outstanding that are used in calculating basic and diluted earnings per limited partnership and general partnership unit. | |
| Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 | us-gaap/2024 | 0 | 0 | monetary | D | D | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Equipment And Leasehold Improvements Net | 0001079973-25-000729 | 1 | 0 | monetary | I | D | Equipment and leasehold improvements, net |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001079973-25-000729 | 2 | 3 | BS | 0 | H | Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001079973-25-000729 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Investments | 0 |
| 0001079973-25-000729 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net of allowance for expected credit losses of $0 at March 31, 2025 and at June 30, 2024, respectively | 0 |
| 0001079973-25-000729 | 2 | 6 | BS | 0 | H | Deferred Costs Current | us-gaap/2024 | Deferred costs | 0 |
| 0001079973-25-000729 | 2 | 7 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0001079973-25-000729 | 2 | 8 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001079973-25-000729 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001079973-25-000729 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Other Net | us-gaap/2024 | Land and building, net | 0 |
| 0001079973-25-000729 | 2 | 11 | BS | 0 | H | Equipment And Leasehold Improvements Net | 0001079973-25-000729 | Equipment and leasehold improvements, net | 0 |
| 0001079973-25-000729 | 2 | 12 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right of use asset, net | 0 |
| 0001079973-25-000729 | 2 | 13 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangibles, net | 0 |
| 0001079973-25-000729 | 2 | 14 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred income taxes, net | 0 |
| 0001079973-25-000729 | 2 | 15 | BS | 0 | H | Long Term Investments | us-gaap/2024 | Investments | 0 |
| 0001079973-25-000729 | 2 | 16 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001079973-25-000729 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001079973-25-000729 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001079973-25-000729 | 2 | 21 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001079973-25-000729 | 2 | 22 | BS | 0 | H | Deferred Revenue Current | us-gaap/2024 | Deferred revenue | 0 |
| 0001079973-25-000729 | 2 | 23 | BS | 0 | H | Accrued Income Taxes Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001079973-25-000729 | 2 | 24 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Note payable | 0 |
| 0001079973-25-000729 | 2 | 25 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001079973-25-000729 | 2 | 26 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease liability, net of current portion | 0 |
| 0001079973-25-000729 | 2 | 27 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Notes payable, net of current portion | 0 |
| 0001079973-25-000729 | 2 | 28 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total non-current liabilities | 0 |
| 0001079973-25-000729 | 2 | 29 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001079973-25-000729 | 2 | 30 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common shares; no par value; 50,000,000 shares authorized; 3,261,043 and 3,363,412 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively | 0 |
| 0001079973-25-000729 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings | 0 |
| 0001079973-25-000729 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders equity | 0 |
| 0001079973-25-000729 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders equity | 0 |
| 0001079973-25-000729 | 3 | 1 | BS | 1 | H | Allowance For Doubtful Accounts Receivable Current | us-gaap/2024 | Net of allowance for expected credit losses | 0 |
| 0001079973-25-000729 | 3 | 2 | BS | 1 | H | Common Stock No Par Value | us-gaap/2024 | Common stock, no par value | 0 |
| 0001079973-25-000729 | 3 | 3 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001079973-25-000729 | 3 | 4 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001079973-25-000729 | 3 | 5 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001079973-25-000729 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Net sales | 0 |
| 0001079973-25-000729 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Cost of sales | 0 |
| 0001079973-25-000729 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001079973-25-000729 | 4 | 5 | IS | 0 | H | Selling Expense | us-gaap/2024 | Selling expenses | 0 |
| 0001079973-25-000729 | 4 | 6 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001079973-25-000729 | 4 | 7 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development costs | 0 |
| 0001079973-25-000729 | 4 | 8 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001079973-25-000729 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating income | 0 |
| 0001079973-25-000729 | 4 | 10 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 1 |
| 0001079973-25-000729 | 4 | 11 | IS | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized gain (loss) on marketable equity investments | 0 |
| 0001079973-25-000729 | 4 | 12 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Interest and other income | 0 |
| 0001079973-25-000729 | 4 | 13 | IS | 0 | H | Equity Method Investment Realized Gain Loss On Disposal | us-gaap/2024 | Gain on sale of investments | 0 |
| 0001079973-25-000729 | 4 | 14 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income before income taxes | 0 |
| 0001079973-25-000729 | 4 | 15 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 0 |
| 0001079973-25-000729 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001079973-25-000729 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net income | 0 |
| 0001079973-25-000729 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net income | 0 |
| 0001079973-25-000729 | 4 | 22 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
| 0001079973-25-000729 | 4 | 23 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
| 0001079973-25-000729 | 4 | 24 | IS | 0 | H | Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted | us-gaap/2024 | Common shares outstanding | 0 |
| 0001079973-25-000729 | 5 | 7 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, beginning of period | 0 |
| 0001079973-25-000729 | 5 | 8 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Share-based compensation expense | 0 |
| 0001079973-25-000729 | 5 | 9 | EQ | 0 | H | Stock Repurchased During Period Value | us-gaap/2024 | Share repurchases | 0 |
| 0001079973-25-000729 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Shares withheld from common stock issued to pay employee payroll taxes | 0 |
| 0001079973-25-000729 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | ESPP shares issued | 0 |
| 0001079973-25-000729 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001079973-25-000729 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, end of period | 0 |
| 0001079973-25-000729 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001079973-25-000729 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001079973-25-000729 | 6 | 5 | CF | 0 | H | Amortization Of Deferred Loan Origination Fees Net | us-gaap/2024 | Amortization of loan fees, net | 1 |
| 0001079973-25-000729 | 6 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001079973-25-000729 | 6 | 7 | CF | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized (gain) loss on marketable equity investments | 1 |
| 0001079973-25-000729 | 6 | 8 | CF | 0 | H | Noncash Straightline Lease Amortization | 0001079973-25-000729 | Non-cash straight-line lease amortization | 0 |
| 0001079973-25-000729 | 6 | 9 | CF | 0 | H | Gain Loss On Sale Of Investments | us-gaap/2024 | Gain on sale of investments | 1 |
| 0001079973-25-000729 | 6 | 10 | CF | 0 | H | Credit Loss Expense | 0001079973-25-000729 | Credit loss expense | 0 |
| 0001079973-25-000729 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001079973-25-000729 | 6 | 13 | CF | 0 | H | Increase Decrease In Deferred Charges | us-gaap/2024 | Deferred costs | 1 |
| 0001079973-25-000729 | 6 | 14 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001079973-25-000729 | 6 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0001079973-25-000729 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001079973-25-000729 | 6 | 17 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue | 0 |
| 0001079973-25-000729 | 6 | 18 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income taxes payable | 0 |
| 0001079973-25-000729 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by (used in) operating activities | 0 |
| 0001079973-25-000729 | 6 | 21 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Purchases of investments | 1 |
| 0001079973-25-000729 | 6 | 22 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of equipment and improvements | 1 |
| 0001079973-25-000729 | 6 | 23 | CF | 0 | H | Proceeds From Sale Of Equity Method Investments | us-gaap/2024 | Proceeds from sale of investments | 0 |
| 0001079973-25-000729 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0001079973-25-000729 | 6 | 26 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2024 | Repurchases of common stock | 1 |
| 0001079973-25-000729 | 6 | 27 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds from exercise of options and ESPP contributions | 0 |
| 0001079973-25-000729 | 6 | 28 | CF | 0 | H | Payments Of Employee Taxes On Net Issuance Of Common Stock | 0001079973-25-000729 | Payment of employee payroll taxes on net issuance of common stock | 1 |
| 0001079973-25-000729 | 6 | 29 | CF | 0 | H | Proceeds From Issuance Of Long Term Debt | us-gaap/2024 | Proceeds from Minnesota Bank & Trust revolving loan, net of fees | 0 |
| 0001079973-25-000729 | 6 | 30 | CF | 0 | H | Repayments Of Notes Payable | us-gaap/2024 | Principal payments on notes payable and revolving loan | 1 |
| 0001079973-25-000729 | 6 | 31 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0001079973-25-000729 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase in cash and cash equivalents | 0 |
| 0001079973-25-000729 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, beginning of period | 0 |
| 0001079973-25-000729 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, end of period | 0 |
| 0001079973-25-000729 | 6 | 36 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid during the period for interest | 0 |
| 0001079973-25-000729 | 6 | 38 | CF | 0 | H | Noncash Or Part Noncash Acquisition Inventory Acquired1 | us-gaap/2024 | Federal income tax payments | 0 |
| 0001079973-25-000729 | 6 | 39 | CF | 0 | H | Noncash Or Part Noncash Acquisition Payables Assumed1 | us-gaap/2024 | California income tax payments | 0 |
| 0001079973-25-000729 | 6 | 40 | CF | 0 | H | Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 | us-gaap/2024 | Massachusetts income tax payments | 0 |
| 0001079973-25-000729 | 6 | 41 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Total income tax payments | 0 |
| 0001079973-25-000729 | 6 | 42 | CF | 0 | H | Noncash Or Part Noncash Acquisition Other Assets Acquired1 | us-gaap/2024 | Cashless stock option exercise | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |